An ongoing outbreak of Bundibugyo virus disease, a species of orthoebolavirus without approved vaccines or treatments, drives trader focus on confirmed cases through 2026. As of mid-June, the Democratic Republic of the Congo reports over 680 confirmed cases and Uganda nearly 20, following the May declaration of a public health emergency of international concern by WHO; conflict, population displacement, and cross-border movement in Ituri and neighboring provinces elevate transmission risk. Authoritative CDC and WHO surveillance shows no confirmed spread beyond these two nations to date, though South Sudan and other neighbors face elevated monitoring. Weekly ministry and WHO situation reports, plus model projections on case growth, represent key upcoming data that could shift probabilities for additional countries recording at least one laboratory-confirmed case by year-end.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedWhich countries will have an Ebola case in 2026?
$14,998 Vol.
South Sudan
65%
Rwanda
56%
Burundi
48%
United States
42%
Canada
31%
Kenya
58%
India
29%
Republic of the Congo
19%
Nigeria
32%
Ethiopia
48%
Somalia
43%
China
31%
$14,998 Vol.
South Sudan
65%
Rwanda
56%
Burundi
48%
United States
42%
Canada
31%
Kenya
58%
India
29%
Republic of the Congo
19%
Nigeria
32%
Ethiopia
48%
Somalia
43%
China
31%
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Market Opened: May 22, 2026, 12:35 PM ET
Resolver
0x65070BE91...Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Resolver
0x65070BE91...An ongoing outbreak of Bundibugyo virus disease, a species of orthoebolavirus without approved vaccines or treatments, drives trader focus on confirmed cases through 2026. As of mid-June, the Democratic Republic of the Congo reports over 680 confirmed cases and Uganda nearly 20, following the May declaration of a public health emergency of international concern by WHO; conflict, population displacement, and cross-border movement in Ituri and neighboring provinces elevate transmission risk. Authoritative CDC and WHO surveillance shows no confirmed spread beyond these two nations to date, though South Sudan and other neighbors face elevated monitoring. Weekly ministry and WHO situation reports, plus model projections on case growth, represent key upcoming data that could shift probabilities for additional countries recording at least one laboratory-confirmed case by year-end.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions